Mankind Pharma Limited (BOM:543904)
India
· Delayed Price · Currency is INR 2,352.90
-8.35 (-0.35%)
At close: Jun 6, 2025
Mankind Pharma Revenue
In the fiscal year ending March 31, 2025, Mankind Pharma had annual revenue of 122.07B INR with 18.12% growth. Mankind Pharma had revenue of 30.79B in the quarter ending March 31, 2025, with 26.15% growth.
Revenue
122.07B
Revenue Growth
+18.12%
P/S Ratio
7.95
Revenue / Employee
6.25M
Employees
19,540
Market Cap
970.77B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |